|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Cash | |||||||||
| Total current assets | |||||||||
| Intangible assets | |||||||||
| Total assets | |||||||||
| Accounts payable and accrued liabilities | |||||||||
| Notes payable - related party | |||||||||
| Notes payable | |||||||||
| Convertible notes payable | |||||||||
| Total current liabilities | |||||||||
| Total liabilities | |||||||||
| Preferred stock, value | |||||||||
| Series A Preferred Stock | |||||||||
| Series B Preferred Stock | |||||||||
| Preferred Stock | |||||||||
| Series C Preferred Stock | |||||||||
| Total preferred stock, value | |||||||||
| Common stock, $0.001 par value, 700,000,000 shares authorized, 36,134,795 and 44,296,895 and shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | |||||||||
| Additional paid in capital | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders' equity (deficit) | |||||||||
| Total liabilities and stockholders' equity (deficit) |
Loading...